| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 04/19/2001 | WO2001026667A1 Tenocyte compositions and production and uses thereof |
| 04/19/2001 | WO2001026470A1 Suppressor cells for prevention and treatment of immune responses in transplantation |
| 04/19/2001 | WO2001026459A2 Flowering time modification |
| 04/19/2001 | WO2001026458A2 Process for increasing crop yield or biomass using protoporphyrinogen oxidase gene |
| 04/19/2001 | WO2001026453A1 Atp-binding cassette transporter (abc1) modified transgenic mice |
| 04/19/2001 | WO2001007572A3 Dna recombination in eukaryotic cells by the bacteriophage phic31 recombination system |
| 04/19/2001 | WO2001002565A3 Secreted protein zacrp4 |
| 04/19/2001 | WO2000078986B1 Regulation system of expression using nuclear ppar receptors |
| 04/19/2001 | WO2000077170A3 Ex-vivo propagation of kidney |
| 04/19/2001 | WO2000070015A3 Cultures of insect cells which reproduce at 37 °c, method for obtaining said cultures and their uses |
| 04/19/2001 | WO2000068380A3 Extracellular matrix and adhesion-associated proteins |
| 04/19/2001 | WO2000066730A3 Laminin 2 and methods for its use |
| 04/19/2001 | WO2000066712A3 Modular cell carrier systems for the three-dimensional cell growth |
| 04/19/2001 | WO2000065073A3 Genetic sequence which codes for the flavon synthase ii enzyme and use of the same |
| 04/19/2001 | WO2000060061A3 Transgenic plant resistant to mycotoxins and methods |
| 04/19/2001 | WO2000060060A3 Polypeptides having alkaline alpha-amylase activity and nucleic acids encoding same |
| 04/19/2001 | WO2000055621A3 Blood leucocyte apheresis for treatment of disease |
| 04/19/2001 | WO2000053728A3 Method for cultivating cancer cells from human tissue and device for preparing tissue samples |
| 04/19/2001 | WO2000029444A9 Generation of antibodies using polynucleotide vaccination in avian species |
| 04/19/2001 | WO2000026245A3 Human membrane transport proteins |
| 04/19/2001 | WO2000012720A9 Elongase genes and uses thereof |
| 04/19/2001 | WO1999064566A3 In vitro maintenance of hematopoietic stem cells |
| 04/19/2001 | WO1999056785A3 Cell mediated gene delivery using muscle derived cells for treating muscle-and bone-related injury or dysfunction |
| 04/19/2001 | WO1999053022A3 Selection of lineage specific cells after differentiation of progenitor cells |
| 04/19/2001 | US20010000324 Inducing differentiation of less differentiated passaged cells by contacting the cells with initially passaged, more differentiated cells of the same type; produced pancreatic islet cell aggregates useful for treating diabetes |
| 04/19/2001 | DE19948120A1 3D-Matrix zur Herstellung von Zelltransplantaten 3D-matrix for the preparation of cell grafts |
| 04/19/2001 | DE10030529A1 New ester-cleaving enzyme from Thermomonospora fusca, useful for degrading e.g. polyesters, for recycling or surface modification |
| 04/19/2001 | CA2387605A1 High yield protein expression system and methods |
| 04/19/2001 | CA2387541A1 Short segments of dap-kinase |
| 04/19/2001 | CA2387484A1 Adeno-associated virus vectors encoding factor viii and methods of using the same |
| 04/19/2001 | CA2387237A1 Novel human potassium channel subunit |
| 04/19/2001 | CA2387184A1 Cell-permeable peptide inhibitors of the jnk signal transduction pathway |
| 04/19/2001 | CA2387063A1 Activation of antigen-specific t cells by virus/antigen-treated dendritic cells |
| 04/19/2001 | CA2386181A1 Converting diploidy to haploidy for genetic diagnosis |
| 04/19/2001 | CA2386170A1 Flowering time modification |
| 04/19/2001 | CA2385907A1 Methods to identify compounds that modulate neuronal activity |
| 04/19/2001 | CA2385792A1 Generation and characterization of a dendritic cell isolated from human peripheral blood mononuclear cells |
| 04/19/2001 | CA2385784A1 Antimicrobial compositions comprising multidrug efflux pumps |
| 04/19/2001 | CA2385196A1 Aortic carboxypeptidase-like protein and nucleic acids encoding same |
| 04/19/2001 | CA2385154A1 Atp-binding cassette transporter (abc1) modified transgenic mice |
| 04/19/2001 | CA2383969A1 Recombinant megalomicin biosynthetic genes and uses thereof |
| 04/19/2001 | CA2383642A1 Anthozoa derived chromophores/fluorophores and methods for using the same |
| 04/19/2001 | CA2382737A1 Suppressor cells for prevention and treatment of immune responses in transplantation |
| 04/19/2001 | CA2382658A1 Process for increasing crop yield or biomass using protoporphyrinogen oxidase gene |
| 04/18/2001 | EP1092779A1 Lentiviral vectors for the preparation of immunotherapeutical compositions |
| 04/18/2001 | EP1092777A1 Self-cleaving RNA sequences and their use for the control of protein synthesis. |
| 04/18/2001 | EP1092775A1 Methods for identifiying non-essential genes of the human cytomegalovirus genome and for screening for inhibitors of human cytomegalovirus |
| 04/18/2001 | EP1092772A1 Antibody against lar phosphatase subunit |
| 04/18/2001 | EP1092771A2 Tetracycline-regulated transcriptional modulators |
| 04/18/2001 | EP1092770A2 Human cancer antigen of tyrosinase-related protein 1 and 2 and genes encoding same |
| 04/18/2001 | EP1092767A1 Serine protease-specific monoclonal antibody and utilization thereof |
| 04/18/2001 | EP1092727A2 G-protein receptor |
| 04/18/2001 | EP1092439A1 Activation of antigen-specific T cells by virus/antigen-treated dendritic cells |
| 04/18/2001 | EP1092436A1 Tenocyte compositions, preparation and use |
| 04/18/2001 | EP1092037A1 Cell culture process for producing glycoproteins |
| 04/18/2001 | EP1092035A2 Targeted integration into chromosomes using retroviral vectors |
| 04/18/2001 | EP1092032A2 Human oxidoreductase proteins |
| 04/18/2001 | EP1092030A2 Flt3-l mutants and methods of use |
| 04/18/2001 | EP1092029A1 A novel human thrombopoietin mutein |
| 04/18/2001 | EP1092027A1 Therapeutic and diagnostic domain 1 beta 2 gp1 polypeptides and methods of using same |
| 04/18/2001 | EP1092026A2 Neurotransmission associated proteins |
| 04/18/2001 | EP1092025A1 Human emr1-like g protein coupled receptor |
| 04/18/2001 | EP1092024A2 14273 receptor, a g-protein coupled receptor |
| 04/18/2001 | EP1092023A2 Molecules associated with apoptosis |
| 04/18/2001 | EP1092022A2 Immune system molecules |
| 04/18/2001 | EP1092021A1 Npy-y7 receptor gene |
| 04/18/2001 | EP1092020A1 A nucleic acid encoding a retinoblastoma binding protein (rbp-7) and polymorphic markers associated with said nucleic acid |
| 04/18/2001 | EP1092019A1 Human homologue of unc-53 protein of c. elegans |
| 04/18/2001 | EP1092018A1 Kv6.2, A VOLTAGE-GATED POTASSIUM CHANNEL SUBUNIT |
| 04/18/2001 | EP1092017A1 Novel gaba-b receptor |
| 04/18/2001 | EP1092010A2 Porcine spinal cord cells and their use in spinal cord repair |
| 04/18/2001 | EP1091971A2 Polyketides and their synthesis |
| 04/18/2001 | EP0852011A4 ANTIBODIES SPECIFIC FOR NATIVE PrP?Sc |
| 04/18/2001 | EP0671923B1 Liver reserve cells |
| 04/18/2001 | EP0604635B1 Macrophage cell line for an antinuclear antibody test; a method for detecting the said antibody by employing the macrophage cell line and a slide preparation |
| 04/18/2001 | CN1292032A Self-regulated apoptosis of inflammatory cells by gene therapy |
| 04/18/2001 | CN1292029A Compounds for therapy and diagnosis for lung cancer and method for their use |
| 04/18/2001 | CN1291860A Particle bombardment transformation of i (brassica) |
| 04/18/2001 | CN1064710C Therapeutic uses of keratinocyte growth factor |
| 04/17/2001 | US6218510 Proteins associated with the activation of lymphocytes and monocytes; for treatment of immune defects |
| 04/17/2001 | US6218188 Polynucleotide sequence for expression of pesticide in eukaryotic cells; for biological pest control |
| 04/17/2001 | US6218187 Infect human stem cells with microoganism supernatant; transfect cells, separate cells from supernatant, add adhesion molecules to culture plates, propagate second group of cells with supernantant and recover transduced cells |
| 04/17/2001 | US6218182 Method for culturing three-dimensional tissue in diffusion gradient bioreactor and use thereof |
| 04/17/2001 | US6218181 Retroviral packaging cell line |
| 04/17/2001 | US6218180 Virion coding a toxic agent, cytokine and tumor suppressor; for the treatment of tumorous defects; antitumor agents |
| 04/17/2001 | US6218168 Process for preparing O-acetylserine, L-cysteine and L-cysteine-related products |
| 04/17/2001 | US6218165 Protease with altered t-cell epitopes; prevents sensitization of individual to protein; detergents; treatment of wool to prevent felting; soaps; cosmetics; skin care |
| 04/17/2001 | US6218159 Amino acid sequence; bacteriostats; bactericides; antibiotics; diagnosis of infections; drug screening |
| 04/17/2001 | US6218148 DNS encoding stem cell factor |
| 04/17/2001 | US6218146 MTS2 gene |
| 04/17/2001 | US6218132 Activating t-cells with antigen to cause expansion, reactivating with antigen and antigen presenting cells to induce secretion of soluble factor, then detecting by capturing factor on solid support |
| 04/17/2001 | US6218113 Human protein kinase C inhibitor |
| 04/17/2001 | US6218103 Screening method by infecting cell having us3 gene under control of immediate early promoter with herpes virus lacking functional us3 gene, contacting with test compound, incubating for viral replication, comparing pathology with control |
| 04/17/2001 | US6217861 pneumococcus; use as drug target for drug screening antibiotics |
| 04/17/2001 | CA2210506C Thermostable dna polymerase from bacillus pallidus |
| 04/17/2001 | CA2131355C Production of a single-gene-encoded immunoglobulin |
| 04/13/2001 | CA2321260A1 Oral immunology using plant product containing hepatitis surface antigen |
| 04/12/2001 | WO2001025466A1 Producer cell for the production of retroviral vectors |
| 04/12/2001 | WO2001025465A1 Adeno-associated viruses and uses thereof |
| 04/12/2001 | WO2001025446A1 Dna encoding prost 07 polypeptide |